Favisme
Revu par Dr Hannah Gronow, MBACPDernière mise à jour par Dr Louise Newson, MRCGPLast updated 21 Sept 2015
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
Cette page a été archivée.
Il n'a pas été révisé récemment et n'est pas à jour. Les liens externes et les références peuvent ne plus fonctionner.
Professionnels de la santé
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our articles de santé more useful.
Dans cet article:
See also separate Glucose-6-phosphate Dehydrogenase Deficiency article.
Favism describes the susceptibility to, and clinical presentation of, acute haemolytic crises as a consequence of eating broad beans in a subgroup of patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
It can be potentially life-threatening. Broad beans are derived from the plant Vicia fava - hence, the condition's name. Susceptible patients may also experience the syndrome when exposed to the plant's pollen.
G6PD is crucial in maintaining red cell homeostasis and its deficiency leads to increased susceptibility to haemolysis induced by drugs, infections and substances in food. There is a huge number of polymorphisms of the gene with variable effects on the activity of the enzyme and a wide range of phenotypic susceptibility to haemolysis.
Continuez à lire ci-dessous
Génétique
The gene for G6PD is located on the X chromosome. It is therefore an X-linked inherited disease that primarily affects men. It can have clinical effects in homozygous women and a proportion of female heterozygous carriers.
It is thought that the susceptibility to favism is determined by a combination of the particular G6PD polymorphism and other factors, such as genetics and also metabolism of the active ingredients in the beans, which causes oxidative damage in red blood cells. An infectious agent such as a virus may also play a role in the development of favism.1
Épidémiologie
Retour au sommaireG6PD deficiency is the most common enzymopathy of man of clinical significance. It affects more than 400 million people worldwide.2
Patients with favism are always G6PD-deficient but not all G6PD-deficient individuals develop haemolysis when they ingest fava beans.
The vast majority of cases of favism occur in individuals with severely deficient variants of G6PD.
Favism is more common in males than in females.3
Continuez à lire ci-dessous
Présentation
Retour au sommaireThere may be a past history of episodes of neonatal or childhood jaundice.
A dietary history may reveal recent ingestion of broad beans.
Check for recent medication changes or history consistent with infection.
Favism leads to acute, massive intravascular haemolysis. Its main clinical features are:
Acute back and/or abdominal pain.
Acute pallor due to anaemia.
Haemoglobinuria causing the passage of dark or orangey-yellow urine.
Jaundice.
Patients with G6PD deficiency are prone to gallstones and splenomegaly due to recurrent, often subclinical, episodes of haemolysis.
Diagnostic différentiel
Retour au sommaireAcute haemolysis caused by an alternative precipitant in those with G6PD deficiency - eg, drugs, particularly antimalarials or infection.
Exacerbation of other haemolytic anaemias - eg, sphérocytose héréditaire, l'anémie hémolytique auto-immune.
Continuez à lire ci-dessous
Enquêtes
Retour au sommaireDipstick urine testing to reveal evidence of haemoglobinuria.
FBC will show acute haemolytic anaemia picture with low haemoglobin.
Reticulocyte count may be elevated (although often normal in the early acute phase).
Raised indirect bilirubin (unconjugated) indicating haemolysis.
LFTs are usually normal.
Serum lactate dehydrogenase may be elevated, indicating haemolysis.
Serum haptoglobins may be low, indicating haemolysis.
Abdominal ultrasound may be used to detect gallstones and/or splenomegaly.
Coombs' test is negative.
G6PD activity assay in undiagnosed cases - may be normal if there is significant reticulocytosis, as reticulocytes are rich in the enzyme; assay may need to be repeated in the convalescent phase.
Maladies associées
Retour au sommaireCalculs biliaires due to chronic haemolysis.
Splenomegaly due to chronic haemolysis.
Gestion
Retour au sommaireAvoid further ingestion of broad beans.
Folic acid supplementation.
Iron supplementation if there is ongoing acute severe intravascular haemolysis.
Oxygen therapy.
Bed rest and transfer to a high care/intensive care setting.
Intravenous fluids to reduce the chance of acute oliguric renal impairment.
Blood transfusion or exchange transfusion is sometimes needed to treat severe anaemia.
Complications
Retour au sommaireDeath due to acute severe haemolytic anaemia (relatively rare).
Ophthalmological damage due to intraocular intravascular haemolysis.
Susceptibility to infection.
Pronostic
Retour au sommaireThis is variable depending on the degree of susceptibility to favism, quantity of beans ingested and access to acute medical care. Most cases do well with supportive care but there is significant morbidity and some mortality associated with the disease.
Prévention
Retour au sommaireAvoidance of ingestion of broad beans in patients known to have G6PD deficiency, or who have suffered previous episodes of favism.
However, one study found that the majority of patients who ate fava beans after an attack had no symptoms.1.
Conseil génétique and screening may be useful where there is a family history of G6PD deficiency, to allow diagnosis before exposure to haemolytic precipitants.
Population screening and health education programmes in areas of high prevalence of G6PD deficiency have been shown to reduce the incidence of favism in the at-risk population.4
See separate article on G6PD deficiency for a list of medications to be avoided in G6PD-deficient patients.
Lectures complémentaires et références
- Ahmed SN; Do favic patients resume fava beans ingestion later in their life, a study for this, and a new hypothesis for favism etiology. Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):9-13. doi: 10.1016/j.hemonc.2013.03.002. Epub 2013 Mar 22.
- Osman HG, Zahran FM, El-Sokkary AM, et al; Identification of Mediterranean mutation in Egyptian favism patients. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2821-7.
- Osman HG, Zahran FM, El-Sokkary AM, et al; Oxidative stress and antioxidant defense in Egyptian favism patients. Eur Rev Med Pharmacol Sci. 2013 May;17(9):1211-7.
- Verma IC, Puri RD; Global burden of genetic disease and the role of genetic screening. Semin Fetal Neonatal Med. 2015 Aug 3. pii: S1744-165X(15)00078-5. doi: 10.1016/j.siny.2015.07.002.
Continuez à lire ci-dessous
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
21 Sept 2015 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement